Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumitoshi Kodaka

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Nuclear Medicine and Biology|October 1, 2013
Biodistribution and radiation dosimetry in humans of [¹¹C]FLB 457, a positron emission tomography ligand for the extrastriatal dopamine D₂ receptorYasuyuki Kimura, Hiroshi Ito, Takahiro Shiraishi, et al.
Neuroreport|July 1, 2022
Repetitive transcranial magnetic stimulation decreased effortful frontal activity for shifting in patients with major depressive disorderYuka Shirakawa, Ryuichi Yamazaki, Yosuke Kita, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 7, 2023
Personality Traits Associated with Treatment Choice with an Explicit Statistical Prediction After an Explanation in a Negative Context: A Study in Patients with GlaucomaFumitoshi Kodaka, Takahiko Noro, Nanami Kishimoto, et al.
BMJ Open Ophthalmology|September 26, 2022
Association between personality traits and experience of adverse periocular reactions to topical prostaglandin analoguesNanami Kishimoto, Takahiko Noro, Fumitoshi Kodaka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 15, 2012
Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]racloprideFumitoshi Kodaka, Hiroshi Ito, Yasuyuki Kimura, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 14, 2008
Differential contributions of prefrontal and hippocampal dopamine D(1) and D(2) receptors in human cognitive functionsHidehiko Takahashi, Motoichiro Kato, Harumasa Takano, et al.
Psychiatry Research|August 17, 2025
"Discrepancy between subjective and objective assessments focusing on item-level symptom improvement in repetitive transcranial magnetic stimulation therapy for treatment-resistant depression: A two-site prospective study"Shun Igarashi, Yuki Matsuda, Daisuke Hayashi, et al.
Psychiatry Research|February 28, 2026
Psychiatrists' adherence to guideline-recommended pharmacotherapy for schizophrenia affects subcortical structural alterations in the brains of patients with schizophreniaKentaro Fukumoto, Kazutaka Ohi, Satsuki Ito, et al.
The International Journal of Neuropsychopharmacology|September 24, 2010
Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphineFumitoshi Kodaka, Hiroshi Ito, Harumasa Takano, et al.
Neuroimage|June 29, 2017
Normative data of dopaminergic neurotransmission functions in substantia nigra measured with MRI and PET: Neuromelanin, dopamine synthesis, dopamine transporters, and dopamine D<sub>2</sub> receptorsHiroshi Ito, Hiroshi Kawaguchi, Fumitoshi Kodaka, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Nuclear Medicine and Biology|October 1, 2013
Biodistribution and radiation dosimetry in humans of [¹¹C]FLB 457, a positron emission tomography ligand for the extrastriatal dopamine D₂ receptorYasuyuki Kimura, Hiroshi Ito, Takahiro Shiraishi, et al.
Neuroreport|July 1, 2022
Repetitive transcranial magnetic stimulation decreased effortful frontal activity for shifting in patients with major depressive disorderYuka Shirakawa, Ryuichi Yamazaki, Yosuke Kita, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 7, 2023
Personality Traits Associated with Treatment Choice with an Explicit Statistical Prediction After an Explanation in a Negative Context: A Study in Patients with GlaucomaFumitoshi Kodaka, Takahiko Noro, Nanami Kishimoto, et al.
BMJ Open Ophthalmology|September 26, 2022
Association between personality traits and experience of adverse periocular reactions to topical prostaglandin analoguesNanami Kishimoto, Takahiko Noro, Fumitoshi Kodaka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 15, 2012
Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]racloprideFumitoshi Kodaka, Hiroshi Ito, Yasuyuki Kimura, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 14, 2008
Differential contributions of prefrontal and hippocampal dopamine D(1) and D(2) receptors in human cognitive functionsHidehiko Takahashi, Motoichiro Kato, Harumasa Takano, et al.
Psychiatry Research|August 17, 2025
"Discrepancy between subjective and objective assessments focusing on item-level symptom improvement in repetitive transcranial magnetic stimulation therapy for treatment-resistant depression: A two-site prospective study"Shun Igarashi, Yuki Matsuda, Daisuke Hayashi, et al.
Psychiatry Research|February 28, 2026
Psychiatrists' adherence to guideline-recommended pharmacotherapy for schizophrenia affects subcortical structural alterations in the brains of patients with schizophreniaKentaro Fukumoto, Kazutaka Ohi, Satsuki Ito, et al.
The International Journal of Neuropsychopharmacology|September 24, 2010
Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphineFumitoshi Kodaka, Hiroshi Ito, Harumasa Takano, et al.
Neuroimage|June 29, 2017
Normative data of dopaminergic neurotransmission functions in substantia nigra measured with MRI and PET: Neuromelanin, dopamine synthesis, dopamine transporters, and dopamine D<sub>2</sub> receptorsHiroshi Ito, Hiroshi Kawaguchi, Fumitoshi Kodaka, et al.
Pageof 7